AbbVie Inc. — Director's Dealing 2017

Aug 4, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2017-08-03

Reporting Person: GONZALEZ RICHARD A (Director, Chairman of the Board and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-08-03	Common stock, $0.01 par value	M	65861	$51.42	Acquired	342353	Direct
2017-08-04	Common stock, $0.01 par value	M	22038	$51.42	Acquired	364391	Direct
2017-08-03	Common stock, $0.01 par value	S	65826	$71	Disposed	298565	Direct
2017-08-03	Common stock, $0.01 par value	S	35	$71.005	Disposed	298530	Direct
2017-08-04	Common stock, $0.01 par value	S	101	$71	Disposed	298429	Direct
2017-08-04	Common stock, $0.01 par value	S	15600	$71.0600	Disposed	282829	Direct
2017-08-04	Common stock, $0.01 par value	S	3000	$71.0700	Disposed	279829	Direct
2017-08-04	Common stock, $0.01 par value	S	1900	$71.0800	Disposed	277929	Direct
2017-08-04	Common stock, $0.01 par value	S	500	$71.1050	Disposed	277429	Direct
2017-08-04	Common stock, $0.01 par value	S	200	$71.1100	Disposed	277229	Direct
2017-08-04	Common stock, $0.01 par value	S	737	$71.1300	Disposed	276492	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-08-03	Option (right to buy)	$51.42	M	65861	Disposed	2024-02-19	Common stock (65861)	Direct
2017-08-04	Option (right to buy)	$51.42	M	22038	Disposed	2024-02-19	Common stock (22038)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock, $0.01 par value	4600	Indirect
Common stock, $0.01 par value	450	Indirect
Common stock, $0.01 par value	450	Indirect

Footnotes

F1: The reporting person disclaims beneficial ownership of these securities.

F2: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.